Logo image of BAMNB.AS

KONINKLIJKE BAM GROEP NV (BAMNB.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:BAMNB - NL0000337319 - Common Stock

9.315 EUR
-0.11 (-1.11%)
Last: 1/9/2026, 10:46:29 AM
Fundamental Rating

4

BAMNB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 43 industry peers in the Construction & Engineering industry. BAMNB has an average financial health and profitability rating. BAMNB is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BAMNB was profitable.
In the past year BAMNB had a positive cash flow from operations.
Of the past 5 years BAMNB 4 years were profitable.
Of the past 5 years BAMNB 4 years had a positive operating cash flow.
BAMNB.AS Yearly Net Income VS EBIT VS OCF VS FCFBAMNB.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

BAMNB's Return On Assets of 3.35% is in line compared to the rest of the industry. BAMNB outperforms 41.86% of its industry peers.
With a Return On Equity value of 14.54%, BAMNB is not doing good in the industry: 62.79% of the companies in the same industry are doing better.
With a decent Return On Invested Capital value of 10.28%, BAMNB is doing good in the industry, outperforming 60.47% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BAMNB is below the industry average of 11.39%.
The last Return On Invested Capital (10.28%) for BAMNB is above the 3 year average (8.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.35%
ROE 14.54%
ROIC 10.28%
ROA(3y)3.76%
ROA(5y)1.87%
ROE(3y)16.79%
ROE(5y)6.44%
ROIC(3y)8.76%
ROIC(5y)N/A
BAMNB.AS Yearly ROA, ROE, ROICBAMNB.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

Looking at the Profit Margin, with a value of 1.93%, BAMNB is doing worse than 72.09% of the companies in the same industry.
BAMNB's Profit Margin has improved in the last couple of years.
The Operating Margin of BAMNB (2.56%) is worse than 76.74% of its industry peers.
BAMNB's Operating Margin has improved in the last couple of years.
BAMNB has a Gross Margin of 27.79%. This is in the lower half of the industry: BAMNB underperforms 74.42% of its industry peers.
BAMNB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.56%
PM (TTM) 1.93%
GM 27.79%
OM growth 3Y23.98%
OM growth 5Y26.14%
PM growth 3Y72.61%
PM growth 5Y50.49%
GM growth 3Y-22.03%
GM growth 5Y-14.4%
BAMNB.AS Yearly Profit, Operating, Gross MarginsBAMNB.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BAMNB is still creating some value.
BAMNB has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BAMNB has less shares outstanding
BAMNB has a worse debt/assets ratio than last year.
BAMNB.AS Yearly Shares OutstandingBAMNB.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
BAMNB.AS Yearly Total Debt VS Total AssetsBAMNB.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

BAMNB has a debt to FCF ratio of 1.77. This is a very positive value and a sign of high solvency as it would only need 1.77 years to pay back of all of its debts.
BAMNB's Debt to FCF ratio of 1.77 is fine compared to the rest of the industry. BAMNB outperforms 79.07% of its industry peers.
BAMNB has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.29, BAMNB is in the better half of the industry, outperforming 69.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.77
Altman-Z N/A
ROIC/WACC1.45
WACC7.11%
BAMNB.AS Yearly LT Debt VS Equity VS FCFBAMNB.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

BAMNB has a Current Ratio of 0.97. This is a bad value and indicates that BAMNB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BAMNB (0.97) is worse than 65.12% of its industry peers.
A Quick Ratio of 0.76 indicates that BAMNB may have some problems paying its short term obligations.
BAMNB has a Quick ratio of 0.76. This is amonst the worse of the industry: BAMNB underperforms 81.40% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.76
BAMNB.AS Yearly Current Assets VS Current LiabilitesBAMNB.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

BAMNB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.63%.
BAMNB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.63% yearly.
Looking at the last year, BAMNB shows a small growth in Revenue. The Revenue has grown by 3.64% in the last year.
The Revenue has been decreasing by -2.10% on average over the past years.
EPS 1Y (TTM)-21.63%
EPS 3Y67.62%
EPS 5Y49.63%
EPS Q2Q%90%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y-4.08%
Revenue growth 5Y-2.1%
Sales Q2Q%7.32%

3.2 Future

The Earnings Per Share is expected to grow by 21.31% on average over the next years. This is a very strong growth
Based on estimates for the next years, BAMNB will show a small growth in Revenue. The Revenue will grow by 5.39% on average per year.
EPS Next Y50%
EPS Next 2Y28.88%
EPS Next 3Y21.31%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2Y5.04%
Revenue Next 3Y4.5%
Revenue Next 5Y5.39%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BAMNB.AS Yearly Revenue VS EstimatesBAMNB.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
BAMNB.AS Yearly EPS VS EstimatesBAMNB.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.41, the valuation of BAMNB can be described as rather expensive.
Based on the Price/Earnings ratio, BAMNB is valued a bit more expensive than the industry average as 65.12% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.00. BAMNB is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 10.02, the valuation of BAMNB can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BAMNB indicates a rather cheap valuation: BAMNB is cheaper than 81.40% of the companies listed in the same industry.
BAMNB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.70.
Industry RankSector Rank
PE 19.41
Fwd PE 10.02
BAMNB.AS Price Earnings VS Forward Price EarningsBAMNB.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BAMNB.
BAMNB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 12.88
EV/EBITDA 7.83
BAMNB.AS Per share dataBAMNB.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BAMNB's earnings are expected to grow with 21.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.39
PEG (5Y)0.39
EPS Next 2Y28.88%
EPS Next 3Y21.31%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.69%, BAMNB has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.49, BAMNB has a dividend in line with its industry peers.
BAMNB's Dividend Yield is a higher than the S&P500 average which is at 1.94.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

On average, the dividend of BAMNB grows each year by 18.60%, which is quite nice.
Dividend Growth(5Y)18.6%
Div Incr Years2
Div Non Decr Years2
BAMNB.AS Yearly Dividends per shareBAMNB.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

51.48% of the earnings are spent on dividend by BAMNB. This is a bit on the high side, but may be sustainable.
The dividend of BAMNB is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP51.48%
EPS Next 2Y28.88%
EPS Next 3Y21.31%
BAMNB.AS Yearly Income VS Free CF VS DividendBAMNB.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
BAMNB.AS Dividend Payout.BAMNB.AS Dividend Payout, showing the Payout Ratio.BAMNB.AS Dividend Payout.PayoutRetained Earnings

KONINKLIJKE BAM GROEP NV

AMS:BAMNB (1/9/2026, 10:46:29 AM)

9.315

-0.11 (-1.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-06 2025-11-06
Earnings (Next)02-19 2026-02-19
Inst Owners38.94%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap2.53B
Revenue(TTM)6.69B
Net Income(TTM)128.85M
Analysts83.33
Price Target9.44 (1.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.1
Dividend Growth(5Y)18.6%
DP51.48%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)14.55%
PT rev (3m)24.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.56%
EPS NY rev (3m)1.45%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 19.41
Fwd PE 10.02
P/S 0.38
P/FCF 12.88
P/OCF 8.82
P/B 2.86
P/tB 4.94
EV/EBITDA 7.83
EPS(TTM)0.48
EY5.15%
EPS(NY)0.93
Fwd EY9.98%
FCF(TTM)0.72
FCFY7.77%
OCF(TTM)1.06
OCFY11.33%
SpS24.58
BVpS3.26
TBVpS1.89
PEG (NY)0.39
PEG (5Y)0.39
Graham Number5.93
Profitability
Industry RankSector Rank
ROA 3.35%
ROE 14.54%
ROCE 13.71%
ROIC 10.28%
ROICexc 17.19%
ROICexgc 34.4%
OM 2.56%
PM (TTM) 1.93%
GM 27.79%
FCFM 2.94%
ROA(3y)3.76%
ROA(5y)1.87%
ROE(3y)16.79%
ROE(5y)6.44%
ROIC(3y)8.76%
ROIC(5y)N/A
ROICexc(3y)17.07%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.68%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-17.99%
ROICexc growth 3YN/A
ROICexc growth 5Y3.69%
OM growth 3Y23.98%
OM growth 5Y26.14%
PM growth 3Y72.61%
PM growth 5Y50.49%
GM growth 3Y-22.03%
GM growth 5Y-14.4%
F-Score7
Asset Turnover1.74
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 1.77
Debt/EBITDA 0.83
Cap/Depr 66%
Cap/Sales 1.35%
Interest Coverage 9.46
Cash Conversion 93.29%
Profit Quality 152.71%
Current Ratio 0.97
Quick Ratio 0.76
Altman-Z N/A
F-Score7
WACC7.11%
ROIC/WACC1.45
Cap/Depr(3y)71.69%
Cap/Depr(5y)60.2%
Cap/Sales(3y)1.36%
Cap/Sales(5y)1.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.63%
EPS 3Y67.62%
EPS 5Y49.63%
EPS Q2Q%90%
EPS Next Y50%
EPS Next 2Y28.88%
EPS Next 3Y21.31%
EPS Next 5YN/A
Revenue 1Y (TTM)3.64%
Revenue growth 3Y-4.08%
Revenue growth 5Y-2.1%
Sales Q2Q%7.32%
Revenue Next Year6.69%
Revenue Next 2Y5.04%
Revenue Next 3Y4.5%
Revenue Next 5Y5.39%
EBIT growth 1Y17.85%
EBIT growth 3Y18.91%
EBIT growth 5Y23.49%
EBIT Next Year144%
EBIT Next 3Y41%
EBIT Next 5Y32.52%
FCF growth 1Y653.63%
FCF growth 3Y-6.32%
FCF growth 5Y-9.18%
OCF growth 1Y527.86%
OCF growth 3Y-2.61%
OCF growth 5Y-6.77%

KONINKLIJKE BAM GROEP NV / BAMNB.AS FAQ

What is the fundamental rating for BAMNB stock?

ChartMill assigns a fundamental rating of 4 / 10 to BAMNB.AS.


What is the valuation status for BAMNB stock?

ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE BAM GROEP NV (BAMNB.AS). This can be considered as Fairly Valued.


What is the profitability of BAMNB stock?

KONINKLIJKE BAM GROEP NV (BAMNB.AS) has a profitability rating of 4 / 10.


What are the PE and PB ratios of KONINKLIJKE BAM GROEP NV (BAMNB.AS) stock?

The Price/Earnings (PE) ratio for KONINKLIJKE BAM GROEP NV (BAMNB.AS) is 19.41 and the Price/Book (PB) ratio is 2.86.


What is the financial health of KONINKLIJKE BAM GROEP NV (BAMNB.AS) stock?

The financial health rating of KONINKLIJKE BAM GROEP NV (BAMNB.AS) is 4 / 10.